Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.



Current Issue

Biomet Did Not Breach MSA in Settling with M2a Magnum Hip Plaintiff, Ind. Judge Rules

Biomet Inc. did not breach the M2a Magnum hip master settlement agreement by paying a plaintiff $25,000 rather than the $200,000, an Indiana federal judge has ruled, noting the plaintiff did not exercise his option to mediate, and impliedly accepted the settlement when he accepted and retained the reduced award.

FDA Says Trial Results Show Gout Drug Uloric Poses Increased Risk of Heart-Related Death

The Food and Drug Administration has issued an alert that preliminary results from a safety clinical trial show an increased risk of heart-related death with Takeda Pharmaceuticals’ gout drug Uloric (febuxostat) compared to its competitor drug, allopurinol.

Plaintiff Barred from Asserting Autism-Related Claims in Depakote Case Set for Trial

An Illinois federal judge has barred a plaintiff from alleging his in utero exposure to Depakote caused him to develop autism, noting the plaintiff’s expert has never included autism in the list of defects he allegedly suffers from.

Pa. Appellate Court Orders New Trial on Causation, Damages in Risperdal Action

A Pennsylvania intermediate court has ordered a new trial on the issues of causation and damages in a Risperdal action, finding the trial court erred in failing to designate a treating medical provider as an expert because her testimony as to the cause of the plaintiff’s gynecomastia required specialized knowledge.

Pa. Appellate Court Upholds Summary Awards to Janssen in 2 Risperdal Cases, Says Claims Are Time-Barred

A Pennsylvania intermediate court has upheld awards of summary judgment to Janssen Pharmaceuticals Inc. in two Risperdal cases, finding the plaintiffs’ claims were untimely because they were on notice of the cause of their injuries by October 2006, when the drug’s label was changed to include a warning about gynecomastia.

Texas Federal Jury Finds for Ethicon, J&J at Conclusion of Transvaginal Mesh Trial

A Texas federal jury found in favor of Ethicon and Johnson & Johnson at the conclusion of a transvaginal mesh trial, finding the device did not have a design defect that contributed to the plaintiff’s alleged injuries.

Calif. Federal Judge Awards Mentor Summary Judgment in Saline Breast Implant Lawsuit

A California judge has dismissed a woman’s lawsuit alleging defective Mentor breast implants caused her to develop biotoxin disease, ruling her expert’s opinions are unreliable because they did not rule out the plaintiff’s exposure to environmental mold.

Actor Chuck Norris, Wife, Allege Poisoning Caused by Gadolinium-Based Contrast Agent

Film actor Chuck Norris and his wife Gena have sued the makers of gadolinium-based contrast agents, accusing them of failing to warn healthcare providers and patients that their products, which are commonly used during MRIs, can cause gadolinium deposition disease.

Plaintiff May Amend Negligence Claim Against Medtronic in Endurant Aortic Graft Lawsuit

A Missouri federal judge has allowed a plaintiff to amend her negligence claim in which she accuses Medtronic and its sales representative of recommending that a surgeon use the wrong size graft in a patient’s aorta during heart surgery, causing her death.

Defendants Seek Consolidated MDL Docket for Sorin 3T Heater-Cooler Device Cases

Companies accused in numerous federal lawsuits of failing to warn that their warming device poses a risk of infection during surgery have asked a federal judicial panel to transfer all of the cases to South Carolina for pre-trial coordination.

Past Issues:


The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.